76-90 of 183
Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
On the Frontlines of IgA NephropathyDiagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
Gates B. Colbert, MD
Agnes B. Fogo, MD
Advances in IgAN: New Frontiers in Biomarkers and Treatment
On the Frontlines of IgA NephropathyAdvances in IgAN: New Frontiers in Biomarkers and Treatment
Gates B. Colbert, MD
Edward Filippone, MD
Reducing Proteinuria and Function Loss in IgAN: A Recap of the NefigArd Trial
On the Frontlines of IgA NephropathyReducing Proteinuria and Function Loss in IgAN: A Recap of the NefigArd Trial
Jonathan Barratt, MD, PhD
Innovations in IgAN Care: Examining the Evolving Treatment Landscape
On the Frontlines of IgA NephropathyInnovations in IgAN Care: Examining the Evolving Treatment Landscape
Jonathan Barratt, MD, PhD
The Future of IgA Nephropathy: Why Biomarkers Matter
On the Frontlines of IgA NephropathyThe Future of IgA Nephropathy: Why Biomarkers Matter
Jonathan Barratt, MD, PhD
Investigating the Potential Link Between Chronic Tonsillitis and IgA Nephropathy
Clinician's RoundtableInvestigating the Potential Link Between Chronic Tonsillitis and IgA Nephropathy
- advertisement
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Project Oncology®Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Jody Takemoto, PhD, MEd
David Braun
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Project Oncology®The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Jody Takemoto, PhD, MEd
David Braun, MD, PhD
Real-World Data on Treatment Choices for mccRCC
Project Oncology®Real-World Data on Treatment Choices for mccRCC
Nephrotoxicity in the Crosshairs: Optimizing Renal Cancer Care with Kidney Preservation
Project Oncology®Nephrotoxicity in the Crosshairs: Optimizing Renal Cancer Care with Kidney Preservation
Diabetes and CKD: Strategies for Diagnosis and Treatment
Diabetes DiscourseDiabetes and CKD: Strategies for Diagnosis and Treatment
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Ian de Boer, MD
Trimethylamine N-Oxide and CKD: A Concerning Link
Clinician's RoundtableTrimethylamine N-Oxide and CKD: A Concerning Link
- advertisement
Personalized Care for AKI – The Role of Digital Decision Support Tools and Augmented Human Intelligence to Improve Outcomes in AKI
KDIGO Conversations in NephrologyPersonalized Care for AKI – The Role of Digital Decision Support Tools and Augmented Human Intelligence to Improve Outcomes in AKI
Kathleen Liu MD, PhD, FASN, BRCU
Kianoush B. Kashani MD, MS, MSc, FASN, FCCP
Stratifying the Risk of Persistent AKI and Clinical Practice
KDIGO Conversations in NephrologyStratifying the Risk of Persistent AKI and Clinical Practice
Kathleen Liu MD, PhD, FASN, BRCU
Jay L. Koyner, MD
Extracorporeal Blood Purification in the Context of Multiorgan Support: Current Role and Best Practices
KDIGO Conversations in NephrologyExtracorporeal Blood Purification in the Context of Multiorgan Support: Current Role and Best Practices
Kathleen Liu MD, PhD, FASN, BRCU
Professor Claudio Ronco